IL285839A - Antifungal trypanoid for the treatment or prevention of pneumocystis spp pneumonia. - Google Patents

Antifungal trypanoid for the treatment or prevention of pneumocystis spp pneumonia.

Info

Publication number
IL285839A
IL285839A IL285839A IL28583921A IL285839A IL 285839 A IL285839 A IL 285839A IL 285839 A IL285839 A IL 285839A IL 28583921 A IL28583921 A IL 28583921A IL 285839 A IL285839 A IL 285839A
Authority
IL
Israel
Prior art keywords
triterpenoid
antifungals
pneumonia
prevention
treatment
Prior art date
Application number
IL285839A
Other languages
English (en)
Hebrew (he)
Inventor
Gonzalez David A Angulo
Stephen Andrew Barat
Original Assignee
Scynexis Inc
Gonzalez David A Angulo
Stephen Andrew Barat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scynexis Inc, Gonzalez David A Angulo, Stephen Andrew Barat filed Critical Scynexis Inc
Publication of IL285839A publication Critical patent/IL285839A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL285839A 2019-02-27 2021-08-24 Antifungal trypanoid for the treatment or prevention of pneumocystis spp pneumonia. IL285839A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962811456P 2019-02-27 2019-02-27
PCT/US2020/019724 WO2020176527A1 (en) 2019-02-27 2020-02-25 Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia

Publications (1)

Publication Number Publication Date
IL285839A true IL285839A (en) 2021-10-31

Family

ID=70005768

Family Applications (1)

Application Number Title Priority Date Filing Date
IL285839A IL285839A (en) 2019-02-27 2021-08-24 Antifungal trypanoid for the treatment or prevention of pneumocystis spp pneumonia.

Country Status (15)

Country Link
US (1) US12594266B2 (cg-RX-API-DMAC7.html)
EP (1) EP3930716B1 (cg-RX-API-DMAC7.html)
JP (1) JP7581219B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210133241A (cg-RX-API-DMAC7.html)
CN (1) CN113631165A (cg-RX-API-DMAC7.html)
AU (1) AU2020228036B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021016876A2 (cg-RX-API-DMAC7.html)
CA (1) CA3131298A1 (cg-RX-API-DMAC7.html)
EA (1) EA202192344A1 (cg-RX-API-DMAC7.html)
ES (1) ES3055272T3 (cg-RX-API-DMAC7.html)
IL (1) IL285839A (cg-RX-API-DMAC7.html)
MA (1) MA55081A (cg-RX-API-DMAC7.html)
MX (2) MX2021010311A (cg-RX-API-DMAC7.html)
TW (1) TWI910099B (cg-RX-API-DMAC7.html)
WO (1) WO2020176527A1 (cg-RX-API-DMAC7.html)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
WO2010019204A1 (en) 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
CN108883152A (zh) * 2016-01-08 2018-11-23 奇达拉治疗公司 防止和治疗肺孢子虫感染的方法
JP7263313B2 (ja) * 2017-04-10 2023-04-24 サイネクシス,インコーポレーテッド 併用される抗真菌剤
PL3661503T3 (pl) 2017-08-04 2023-01-09 Scynexis, Inc. Środki przeciwgrzybicze o zwiększonej aktywności przy kwasowym odczynie ph

Also Published As

Publication number Publication date
KR20210133241A (ko) 2021-11-05
JP7581219B2 (ja) 2024-11-12
US12594266B2 (en) 2026-04-07
EP3930716A1 (en) 2022-01-05
JP2022523212A (ja) 2022-04-21
MA55081A (fr) 2022-01-05
WO2020176527A1 (en) 2020-09-03
BR112021016876A2 (pt) 2021-11-03
MX2021010311A (es) 2022-01-04
AU2020228036B2 (en) 2025-08-07
AU2020228036A1 (en) 2021-09-23
ES3055272T3 (en) 2026-02-10
MX2025004197A (es) 2025-09-02
US20230149376A1 (en) 2023-05-18
CA3131298A1 (en) 2020-09-03
TW202045169A (zh) 2020-12-16
EA202192344A1 (ru) 2021-11-15
CN113631165A (zh) 2021-11-09
TWI910099B (zh) 2026-01-01
EP3930716B1 (en) 2025-09-10

Similar Documents

Publication Publication Date Title
ZA202002069B (en) Novel mek-inhibitor for the treatment of viral and bacterial infections
MX2020005772A (es) Composiciones que comprenden cepas bacterianas.
MX2021000710A (es) Composiciones que comprenden cepas bacterianas.
PH12019502915A1 (en) Immunogenic compositions
LT3442547T (lt) Lactobacillus reuteri mm4-1a, skirta naudoti autizmo spektro sutrikimų gydymui arba prevencijai
GB201815025D0 (en) Insect-pathogenic fungus, spores, composition and use of same
IL292606A (en) Preventing double activation
IL275573A (en) Methods and preparations for the treatment of hypercytokinemia and severe influenza or for their prevention
GB201911925D0 (en) Formulations for prevention or reduction of c. difficile infections
SG11202001195PA (en) Gyroscope, methods of forming and operating the same
MX2017016114A (es) Metodos para tratar o prevenir una proteopatia.
PL3425377T3 (pl) Detektor promieniowania rentgenowskiego i technika sterowania detektorem promieniowania rentgenowskiego
WO2017049148A8 (en) Compositions and methods for the treatment and prevention of radiation dermatitis
ZA201808182B (en) Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implant infections
EP3165229B8 (en) Composition for the prevention or treatment of polycystic ovary syndrome and its related symptoms
AU2020228036B2 (en) Triterpenoid antifungals for the treatment or prevention of Pneumocystis spp. pneumonia
WO2016135462A8 (en) Treatment
SMT202300391T1 (it) Trattamento della polmonite
IL287840A (en) treatment system
PL3680425T3 (pl) Układ obsługi drzwi oraz drzwi
MX2020003551A (es) Metodos de tratamiento de dolor agudo o cronico.
IL265242B (en) Compounds for the treatment of hypertension and/or fibrosis
PL3618806T3 (pl) Kompozycja do leczenia aft i owrzodzeń jamy ustnej
EP3615043A4 (en) TISSUE CONSTRUCTIONS WITH PANCREAS-DERIVED MICROVASTER FRAGMENTS AND RELATED PROCEDURES
EA202090835A1 (ru) Композиции, содержащие бактериальные штаммы